146 related articles for article (PubMed ID: 1678925)
1. The safety and efficacy of terazosin in the treatment of essential hypertension in blacks.
Saunders E
Am Heart J; 1991 Sep; 122(3 Pt 2):936-42. PubMed ID: 1678925
[TBL] [Abstract][Full Text] [Related]
2. Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials.
Pool JL
Am Heart J; 1991 Sep; 122(3 Pt 2):926-31. PubMed ID: 1678924
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of terazosin in the treatment of essential hypertension in blacks.
Luther RR; Klepper MJ; Maurath CJ; Glassman HN; Achari R; Laddu AR
J Hum Hypertens; 1990 Apr; 4(2):151-3. PubMed ID: 1971027
[TBL] [Abstract][Full Text] [Related]
4. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
Luther RR; Glassman HN; Estep CB; Maurath CJ; Jordan DC
Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
[TBL] [Abstract][Full Text] [Related]
5. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
Itskovitz HD
Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive and metabolic effects of concomitant administration of terazosin and methyclothiazide for the treatment of essential hypertension.
Black HR; Chrysant SG; Curry CL; Frishman WH; Grimm RH; Lasseter KC; Okun R; Pool JL; Raizada V; Vlachakis ND
J Clin Pharmacol; 1992 Apr; 32(4):351-9. PubMed ID: 1349028
[TBL] [Abstract][Full Text] [Related]
7. Experience with terazosin administered in combination with other antihypertensive agents.
Chrysant SG
Am J Med; 1986 May; 80(5B):55-61. PubMed ID: 2872808
[TBL] [Abstract][Full Text] [Related]
8. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
Titmarsh S; Monk JP
Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
[TBL] [Abstract][Full Text] [Related]
9. Terazosin: a new alpha adrenoceptor blocking drug.
Achari R; Laddu A
J Clin Pharmacol; 1992 Jun; 32(6):520-3. PubMed ID: 1353083
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of terazosin alone and in combination with other antihypertensive agents.
Cohen JD
Am Heart J; 1991 Sep; 122(3 Pt 2):919-25. PubMed ID: 1678923
[TBL] [Abstract][Full Text] [Related]
11. Terazosin, a new selective alpha 1-adrenergic blocking agent. Results of long-term treatment in patients with essential hypertension.
Luther RR; Glassman HN; Estep CB; Schmitz PJ; Horton JK; Jordan DC
Am J Hypertens; 1988 Jul; 1(3 Pt 3):237S-240S. PubMed ID: 2901267
[TBL] [Abstract][Full Text] [Related]
12. Terazosin: a new antihypertensive agent with favorable effects on lipids.
Luther RR
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):313-9. PubMed ID: 2570758
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive effects of doxazosin in systemic hypertension and comparison with terazosin.
Hayduk K; Schneider HT
Am J Cardiol; 1987 May; 59(14):95G-98G. PubMed ID: 2884860
[TBL] [Abstract][Full Text] [Related]
14. Terazosin in benign prostatic hyperplasia: effects on blood pressure in normotensive and hypertensive men.
Kirby RS
Br J Urol; 1998 Sep; 82(3):373-9. PubMed ID: 9772873
[TBL] [Abstract][Full Text] [Related]
15. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of terazosin as an antihypertensive agent.
Luther RR; Glassman HN; Jordan DC; Sperzel WD
Am J Med; 1986 May; 80(5B):73-6. PubMed ID: 2872811
[TBL] [Abstract][Full Text] [Related]
17. A multicentre, hospital study of the efficacy and safety of terazosin and its effects on the plasma cholesterol levels of patients with essential hypertension.
Lytle TB; Coles SJ; Waite MA
J Clin Pharm Ther; 1991 Aug; 16(4):263-73. PubMed ID: 1682328
[TBL] [Abstract][Full Text] [Related]
18. Alpha-1-adrenergic blockade and lipoprotein metabolism in essential hypertension.
Ferrier C; Beretta-Piccoli C; Weidmann P; Mordasini R
Clin Pharmacol Ther; 1986 Nov; 40(5):525-30. PubMed ID: 2876796
[TBL] [Abstract][Full Text] [Related]
19. The relationship between terazosin dose and blood pressure response in hypertensive patients.
Achari R; Hosmane B; Bonacci E; O'Dea R
J Clin Pharmacol; 2000 Oct; 40(10):1166-72. PubMed ID: 11028256
[TBL] [Abstract][Full Text] [Related]
20. Comparative trials of terazosin with other antihypertensive agents.
Ruoff G
Am J Med; 1986 May; 80(5B):42-8. PubMed ID: 2872806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
